Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Diagnoplex SA and Unilabs Sign a Collaboration Agreement

Published: Thursday, September 19, 2013
Last Updated: Thursday, September 19, 2013
Bookmark and Share
Agreement to market the Colox® non-invasive colon cancer screening test.

Diagnoplex SA and Unilabs have signed a collaboration agreement to commercialize Colox®, a minimally invasive colorectal cancer assay within the Unilabs network.

The test will be available initially in the Swiss and Swedish markets.

The agreement combines Diagnoplex’s capacity to develop “high-return” molecular assays with Unilabs’ leading position in the European diagnostics market.

The agreement builds on a solid collaborative effort between the two companies and enables Unilabs to further differentiate itself through innovative molecular testing.

“This agreement opens a new and exciting chapter for Diagnoplex” said Stavros Therianos, founder and CEO of Diagnoplex SA. “We are able to enter into a strong collaboration with a European market leader such as Unilabs thanks to a patient- focused strategy for clinical product development. This collaboration demonstrates that a step-by-step approach, for the development of molecular screening tests, can effectively lead to the commercial availability of medically relevant diagnostics”.

Fernando de Górgolas, Unilabs Group Marketing & Business Development Director, said, “This collaboration with Diagnoplex is consistent with our strategy of launching innovative tests, that can bring a real benefit to patients and the healthcare community. Colox will strengthen the role of our molecular genetics laboratories in the diagnosis and monitoring of colorectal cancer.”

Thierry Mauvernay, Delegate of the Board of Debiopharm Group - a lead investor in Diagnoplex - agreed, adding “We are delighted that Diagnoplex has been able to establish this collaboration with an important actor in diagnostic market. We believe the Colox blood test has the potential to greatly increase the percentage of people that will be correctly screened for colorectal cancer”.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
Computational Model Finds New Protein-Protein Interactions
Researchers at University of Pittsburgh have discovered 500 new protein-protein interactions (PPIs) associated with genes linked to schizophrenia.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Insights into Gene Regulation
Researchers have solved the three-dimensional structure of a gene repression complex that is known to play a role in cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!